Recall of ADVIA CENTAUR XP SYS-HIV AG/AB COMBO (CHIV) ASSAY (DONOR SCREEN TRANSPLANT)

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    23494
  • Event Risk Class
    III
  • Event Initiated Date
    2014-03-28
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens healthcare diagnostics has confirmed that certain samples may show human anti-mouse antibodies (hama) interference for the advia centaur hiv ag/ab combo (chiv) assay. heterophilic antibodies in human serum can react with reagent immunoglobulins interfering with in vitro immunoassays. patients routinely exposed to animals or animal serum products are prone to this interference and anomalous values may be observed. additional information may be required for diagnosis.

Device

  • Model / Serial
    Model Catalog: 06520528 (Lot serial: > 10 numbers contact mfg)
  • Product Description
    ADVIA CENTAUR XP SYS-HIV AG/AB COMBO (CHIV) ASSAY (DONOR SCREEN TRANSPLANT)
  • Manufacturer

Manufacturer

  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
  • Source
    HC